Okkeun Jung
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity.
Journal: PloS one
Published: March 28, 2025
Repurposing riluzole as an anti-osteosarcoma agent.
Journal: Frontiers in oncology
Published: October 09, 2024
MARS2 drives metabolic switch of non-small-cell lung cancer cells via interaction with MCU.
Journal: Redox biology
Published: January 15, 2023
Synergistic anticancer effects of timosaponin AIII and ginsenosides in MG63 human osteosarcoma cells.
Journal: Journal of ginseng research
Published: September 18, 2018
Maclurin exerts anti-cancer effects on PC3 human prostate cancer cells via activation of p38 and inhibitions of JNK, FAK, AKT, and c-Myc signaling pathways.
Journal: Nutrition research (New York, N.Y.)
Published: January 15, 2018
Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways.
Journal: Bioorganic & medicinal chemistry letters
Published: March 14, 2016
Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways.
Journal: Chemico-biological interactions
Published: January 23, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026